α-thalassaemia

PYRUVATE KINASE DEFICIENCY | FDA Approves First Drug For The Rare Inherited Anemia

The US Food and Drug Administration (FDA) has announced the approval of Mitapivat (PYRUKYND®) tablets as treatment for haemolytic anemia in adults with pyruvate kinase (PK) deficiency. The oral PK…